化合物SRI-011381 hydrochloride T5129
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mL | 2070014-88-7 | ¥497.00 | 询底价 |
5 mg | 2070014-88-7 | ¥613.00 | 询底价 |
100 mg | 2070014-88-7 | ¥5,770.00 | 询底价 |
10 mg | 2070014-88-7 | ¥1,060.00 | 询底价 |
25 mg | 2070014-88-7 | ¥2,190.00 | 询底价 |
1 mg | 2070014-88-7 | ¥277.00 | 询底价 |
500 mg | 2070014-88-7 | ¥11,500.00 | 询底价 |
2 mg | 2070014-88-7 | ¥389.00 | 询底价 |
50 mg | 2070014-88-7 | ¥3,550.00 | 询底价 |
Product Introduction
Bioactivity
英文名: SRI-011381 hydrochloride
描述: SRI-011381 hydrochloride 是口服具有活力的TGF-β信号通路的激活剂,具有神经保护活性。
体外活性: SRI-11381 is neuroprotective. SRI-011381 promote fibrillar Aβ clearance by macrophages, as demonstrated by the dose-dependent decreases of Aβ in the conditioned medium derived from compound-treated macrophages.
体内活性: SRI-011381 protects mice against kainic acid-induced excitotoxicity and neurodegeneration. SRI-011381 (30 mg/kg, dissolved in DMSO) is injected (i.p.) into the SBE-luc mice. SRI-011381 is rapidly absorbed after oral administration to FBV mice with an oral bioavailability of approximately 50%. SRI-011381 by oral gavage of 10, 30, and 75 mg/kg for 14 days resulted in significant changes in hematological endpoints, most notably reductions in red blood cells, hematocrit and hemoglobin. SRI-011381 reduces neurodegeneratio in APP751Lon, Swetransgenic mice.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 12 mg/mL (32.79 mM)
H2O : 76.92 mg/mL (210 mM)
关键字: SRI 011381 hydrochloride | multiple | Transforming growth factor beta | sclerosis | TGF-beta/Smad | α-SMA | NALP3 | SRI 011381 | collagen-1 | SRI-011381 | inhibit | TGF-β | SRI011381 Hydrochloride | neuroprotective | SRI-011381 Hydrochloride | SRI011381 | Inhibitor | SRI011381 hydrochloride | SRI 011381 Hydrochloride
相关产品: Nisevokitug | A 77-01 | BIBF0775 | Dorsomorphin dihydrochloride | R-268712 | Hesperetin | Alantolactone | LDN-193189 2HCl | Oxymatrine | Hydroxysafflor yellow A
相关库: Anti-Neurodegenerative Disease Compound Library | Anti-Breast Cancer Compound Library | Bioactive Compounds Library Max | CNS-Penetrant Compound Library | Anti-Colorectal Cancer Compound Library | Anti-Fibrosis Compound Library | TGF-beta/Smad Compound Library | Stem Cell Differentiation Compound Library | Anti-Cardiovascular Disease Compound Library | Bioactive Compound Library
化合物SRI-011381 hydrochloride T5129信息由TargetMol中国为您提供,如您想了解更多关于化合物SRI-011381 hydrochloride T5129报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途